EMT + metastasis Flashcards

(87 cards)

1
Q

Define metastasis

A

spread of malignant cells from the primary tumour to other, independent sites within the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain how metastasis is a multistep process

A

Carcinogenesis -> angiogenesis -> Detachment/invasion -> Intravasation -> migration -> extravasation -> micrometastasis -> macrometastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Features of angiogenesis:

A

Formation of blood supply (vascularisation) of tumour

occurs following transformation and initial growth of cells

At tumour size >1 mm, diffusion of nutrients and waste products become rate limiting for continued growth of tumour
-Angiogenesis must occur to provide support for growth of the tumour mass

Synthesis and secretion of pro-angiogenic factors (fibroblast growth factor, FGF; vascular endothelial growth factor, VEGF) by tumour cells and other non-cancerous cell types around cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do cells become metastatic?

A

Initial growth of cancerous cells and formation of a tumour, developing a vascular supply

factors produced by cancerous cells and surrounding non-cancerous cell types stimulate morphological changes in cells

Phenotypic conversion and dedifferentiation of epithelial cells – indicative of carcinoma (epithelial derived cancer)

Characterised by epithelial mesenchymal transition (EMT) enabling cells to migrate and invade the surrounding tissue; invasion of the vascular and lymphatic system → resulting in metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Who proposed the ‘seed and soil’ hypothesis and what is it?

A

Proposed by Stephen Paget (1889) – distribution of metastases is not by chance, instead metastases develop only when ‘seed’ and ‘soil’ are compatible

‘seeds’ - cancer cells with metastatic ability

‘soil’ - microenvironment

3 principle factors

Tumours are heterogeneous made up of cancer cells with subpopulations of host cells (e.g. epithelial, fibroblast, endothelial, leukocytes) exhibiting different properties (angiogenic, invasive, metastatic, growth rate)

Metastasis is selective for cancer cells which demonstrate a combination of these particular properties

Success of the resulting metastasis at the secondary site depends on its ability to interact with and utilise the ‘soil’, comprising multiple factors within the microenvironment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Does bi-directional movement between primary and distant tumour sites exist?

A

Yes

metastases have the ability to re-seed the primary tumour site

suggests that local environments within each site are similar and conducive to tumour growth

This may occur during relapse of disease, following initial treatment phase

Larger the arrow, more common spread to this place happens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Epithelial cells location/function

A

Epithelium sits on top of the connective tissue layer (stroma) – basal lamina (basement membrane – rich in ECM) separates the 2 compartments

Have a barrier function to protect the underlying tissue and also act to selectively sort molecules (by secretion, absorption) between the lumen and the underlying tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is epithelia derived cancer?

A

Development of cancerous growth within the epithelium, leads to disruption of tissue organisation and eventual invasion into the connective tissue layer

colon, breast, ovary, lung, prostate, pancreas – common sites of epithelial-derived cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Epithelial cell structure

A

Polarised cells – has apical and basal domain, and differentiated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain the epithelial junctional complexes

A

Electron microscopy shows 3 sections (Fawcett 1966)

Tight junctions – zipper-like, restricts flow of molecules e.g. ZO-1 and water within the intercellular space, maintains impermeable epithelial barrier

Adherens junctions – (E-cadherin) – provides lateral adhesion between neighbouring epithelial cells – maintains actin contractile ring and epithelial polarity

Desmosomes – linked to intermediate filaments (e.g. cytokeratin), functions to maintain adhesion and tissue integrity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe E-cahedrin cell-cell junctions

A

Ca2+ dependent homodimerization of E-cadherin

linked to actin cytoskeleton

Provides structural support for tissue organisation

supports apical/basal polarity of individual epithelial cells by maintaining actin contractile ring - adhesion belt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe cell-cell adherens junctions

A

Actin contractile ring linked to cell-cell junctions maintains the adhesion belt between cells

Provides structural support to tissue and maintains columnar epithelial phenotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is EMTand ref first discovered

A

Epithelial-mesenchymal transition

First described by the lab of Elizabeth Hay, 1982 – occurs during development of embryo

Reversible phenotypic conversion of polarised (differentiated) epithelial cells to unpolarised mesenchymal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

If you were to look under a microscope at cancer cells undergoing EMT, how would you distinguish between epithelial cells and mesenchymal cells?

A

Epithelial:
E-cahedrin and b-catenin and cell-cell junctions

Mesenchymal:
Loss of E-cahedrin
B-catenin is cytoplasmic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does the TME influence EMT?

A

Tumour microenvironment provides factors and different cell types that promote cancer cell dedifferentiation and metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What factors promote metasiasis and EMT

A

TNFa and IL-1b : pro-inflammatory cytokines that promote remodelling, EMT, invasivness

Secretion of growth factors and ECM - promote cell proliferation, EMT, cell migration/invasion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Features of Transforming growth factor beta1 (TGFβ1)

A

Secreted growth factor, usually has a tumour supressor function

Some oncogenes e.g. Myc, when mutated, allows cells to bypass the checkpoint control of TGFb1

This causes accumulation of TGFb1 and causes it to have a tumour promoting function, promotes EMT invasion/motiliy and inirectly effects angiogenesis and immunosupression

Haynes 2011

learn diagram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Differences in actin between epithelial and mesenchymal

A

Epithelial:
Cortical actin ring

M:
Actin stress fibres

(can see this in the microscope when you add TGFb1 to E cells - see these fibres - Margaret 2008)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Explain what latent TGFb1 is

A

TGFβ1 kept in latent (inactive) form in complex with latent associated peptide (LAP) derived from N-terminal region of TGFβ1 precursor

active/mature TGFβ1 derived from C-terminus, activated by factors - MMPs, ROS, acidic pH, ECM

Heterodimerisation of type I and II receptors, leads to a kinase cascade

Recruitment of R-SMAD (Smad2/3) and phosphorylation

Translocation into nucleus and modulation of gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Factors of epithelial cells

A

E-cadherin

cytokeratin

ZO-1

Desmoplakin

Laminin

Low cell motility, cell-cell adhesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Factors of mesenchymal cells

A

N-cadherin

Vimentin (intermediate filament)

fibronectin

α5β1 integrin receptor

Twist

Slug

Snail

Alpha-smooth muscle actin

High cell motility, cell-ECM adhesion, ECM production and deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is EMT regulated?

A

EMT is a result of transcriptional reprogramming:

Wnt
Transforming growth factor β1 (TGFβ1)
Notch
Epidermal Growth Factor (EGF)
Hepatocyte Growth Factor (HGF)
Tumour necrosis factor α (TNFα)

cause changes in TFs - ZEB1/2, Snail, Twist

leads to either EMT (high vimentin, low E-cad) or MET (Low vimentin, high E-cad)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Role of ZEB

A

ZEB1 – activates DNA repair pathways, promotes cell survival → in an EMT-independent and dependent manner

p53 inhibits ZEB1 expression via microRNA 200 – upon p53 deletion, ZEB1 becomes active and is able to induce EMT; p53 represses Snail expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Regulation on EMT by miRNAs

A

microRNA 200 negatively regulates expression of ZEB1, thus inhibiting EMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Post-translational regulation of EMT
Snail can be phosphorylated at 1st site by GSK3β which leads to its translocation out of the nucleus (e.g. in absence of Wnt signalling) In the cytoplasm, Snail subsequently gets phosphorylated by GSK3β at 2nd site, leading to its ubiquitination and targeting to the proteasome for degradation Alternatively, wild-type p53 induces the mdm2-dependent ubiquitination and degradation of Snail Downregulation of Snail leads to an inhibition of cell migration and invasion
26
Whats a key feature of promoting mesenchymal cell migration?
Remodelling of the actin cytoskeleton:
27
Functions of the actin cytoskeleton
driving membrane protrusion Cell shape changes Maintaining cell-ECM linkages Cell contraction
28
When the TGFb1 receptor gets activated, apart from production of EMT regulator genes, what else happens?
Actiation causes activation of RhoGTPases, which causes the disassembly of adherin junctions and remodelling of the actin cytoskeleton
29
briefly describe the Rho GTPase cycle:
Rho with bound GDP = inactive GEF changes GDP for GTP, Rho with bound GTP is actuve and activates effectors and downstream pathways GAP switches GTP for GDP (making it inactuve) GDI (guanine nucleotide dissociation inhibatir) keeps Rho+GDP bound by binding itself to it (reversable)
30
Give examples of constituativly active GTPases and how expression causes changes in the actin cytoskeleton
All seen microscopically (Hall 1998) RhoA activation: Actin stress fibres and focal adhesion Rac1 activation: Lamellipodia formation - > actin rich membrane ruffles/small focal adhesion contacts Cdc42 activation: Filopodia formation -> finger-like actin protrusions
31
Rho family effectors and function:
Rho family members - bound GTP to be active Effector proteins interact with GTP-bound Rho protein Kinases and actin binding proteins modulate actin e.g.s of Rho family: Rho - contractile phenotyping Rac - Actin polymerisation, actin branching Cdc42 - Actin polymerisation, filopodia
32
Features of focal adhesions
multiprotein complex at the plasma membrane interface – this interaction with extracellular matrix (ECM) mediated by integrin receptors on cell surface actin-binding proteins [α-actinin, vinculin, myosin], signalling proteins [p130Cas, Src, focal adhesion kinase (FAK)], structural proteins [paxillin, talin], integrin receptor provides tensile strength, cell shape, and facilitates membrane protrusion and cell migration – promotes cancer metastasis
33
Integrin receptor family:
Heterodimeric receptors comprising an alpha chain and beta chain – link internal actin cytoskeleton to ECM (except α6β4) Different combinations interact with specific extracellular matrix proteins → provide links from inside to outside of cell (combination of alha and beta components provides specificity
34
Explain focal adhesion signalling
Diamerised integrins, interacting extracellularly with the ECM, have attached intracellularly a series of molecules: vinculin and talin – actin binding proteins paxillin – adaptor protein FAK - structural support and signalling platform Src – tyrosine kinase, signals to Ras (MAPK cascade) and causes Rho GTPase activation This leads to actin cytoskeleton remodelling and focal adhesion formation
35
What faciliates cell movement?
Focal adhesions and actin cytoskeleton
36
Steps to cell movement:
1. extension - actin polymerisation and branching facilitates this 2. Adhesion - focal adhesion formation 3. Translocation - retraction facilitatied by increased tension/contraction 4. De-adhesion - focal adhesions break down
37
Describe the leading edge of a migrating cancer cell
Actin-rich membrane ruffles lamellipodium
38
How does the actin cytoskeleton work?
A linear actin filament (F-actin) is made up of many individual globular actin (G-actin) monomers Each molecule of actin is bound to either ATP or ADP ATP-G-actin is added to the growing (plus) end of the filament and ADP-G-actin is disassembled from the retreating (minus) end of the actin filament
39
Explain actin cytoskeleton organisation at the leading edge of a migrating cell
Lamellipodium further bacj, Filopodium right at the edge Lamellipodium are branched actin, Filopodium are parallel actin, both still have the plus and minus end
40
Explain actin cytoskeleton regulators and cell migration
At the uropod (cell end where migration has come from) - RhoA activation -> ROCK -> pMLC -> increased myosin contractility (actin here is rich in myosin-II -> cross-links actin and contributes to contractility) At the leading end of the cell: Rac1 -> WAVE Cdc42 -> WASP both lead to Arp2/3 activation that promotes branched actin (therefore lamellipodium formation) Cdc42 also leads to mDia (Formin) activation, which is an actin nucleator that promotes actin polymerisation (Filopodia formation)
41
How can collective cell migration be identified
Intact cell-cell junctions
42
Types of cell migration
Collective migration: cell-cell and cell ECM interactions (with some leading cells to cause movment) Mesenchymal cell migration: utelises interactions with the ECM to migrate Amoeboid migration: doesn’t depend on ECM, finds path though chemoattractants Scaffold cell-dependant migration (cell-cell dependant interactions)
43
difference in breast epithelial cells compared to mesenchymal
E - form islands, group together M - Dont group as much, dont form islands
44
Mesenchymal vs. collective cell migration
Mesenchymal & collective – both path-generating Collective – retains cadherin cell-cell junctions, while only exhibiting focalised cell-matrix adhesions and ECM degradation in leader cells RW
45
Table of amoeboid (collective) vs mesencymal
M Vs. A Migration stratagy: Path generating Path finding Mechanisms for. Proteolytic ECM. Mprphalogical overcomig tissue barriers: Degradation. Adaptation Composition of cell-ECM interactions: Focalised Diffuse(integrin-R) integrin-Rs clustered non-clustered
46
MMP features
Zn2+ dependent proteases secreted by cells into extracellular space secreted as an inactive pro-form and following activation in the extracellular space they cleave extracellular matrix proteins and/or activate latent TGFβ1 Regulate migration, invasion, proliferation, differentiation, angiogenesis
47
The action of MT1-MMP in cancer cells
MT1-MMP directly degrades ECM (e.g. basal lamina), allowing cells to invade into underlying connective tissue layer MT1-MMP can activate MMP-2 within connective tissue layer, thus further facilitating cancer cells ability to migrate and invade surrounding tissue MT1-MMP (membrane bound) – transmembrane metalloprotease → directly remodels extracellular matrix (fibronectin, collagen, laminin, vitronectin)
48
Whats a natural inhibator MMP
TIMP-2
49
In terms of MMPs, what is indirect remodelling through?
activation of MMP2
50
Steps of remodelling and MMP-2 activation
1. MT1-MMP monomer expression on the cell surface 2. MT1-MMP dimerization through Hpx and TM domain 3. Formation of activation complex of dimer MT1-MMP, TIMP-2 and proMMP-2 4. Propeptide cleavage by MT1-MMP free from TIMP-2 5. MMP-2 activation by free MT1-MMP subunit by cleavage followed by release of active MMP-2
51
What does TIMP-2 stand for?
Tissue inhibitor of metalloproteinase 2
52
What do levels of TIMP-2 regulate
MMP activation
53
Sites of ECM degradation - invadopodia formation
Cell protrusions of the plasma membrane – filopodia-like structures - actin rich secrete MMPs and degrade extracellular matrix
54
Mechanisms of metastasis
Initiation - by Src kinase Assembly - by proteins attainh to actin Maturation - microtubules connect to the actin RW to check this is correct
55
Define the TME
defined as all the non-transformed elements residing within or in the vicinity of the tumour: Cancer cells Immune cells Cancer-associated fibroblasts Vasculature Extracellular matrix
56
Normal stroma features
cell types and ECM that support the function of any particular organ fibroblasts, adipocytes, macrophages, pericytes provide growth factors, cytokines, and extracellular matrix components Not cancerous themselves, but support tumour growth, influence therapeutic intervention, modulate gene expression
57
Features of tumour stroma
normal stroma - essential for maintenance of epithelial tissue and regulates tissue homeostasis communication between stroma and epithelial cells by direct cell-cell contact or secreted factors during cancer → stroma becomes ‘reactive’ or ‘activated’ - like a wound response to danger signal consists of the non-malignant cells of the tumour and extracellular matrix may act as a physical barrier preventing spread of tumour or therapeutic intervention Or may facilitate metastasis by providing growth factors, secreting ECM, or degrading ECM
58
Factors in the tumour microenvironment influencing cell motility/metastasis
ROS - caused by hypoxia, CAMS and CAFs RNS - caused by CAMs Endothelial precurosir cells ECM stifness Acidity (lowering of pH)
59
Define ECM
molecules secreted by cells that provide structural support and biochemical interactions composed of proteins, glycoproteins, proteoglycans, and polysaccharides – give structura; support ans organisation Some proteins interact with cell surface receptors
60
Types of ECM components:
molecules secreted by cells that provide structural support and biochemical interactions composed of proteins, glycoproteins, proteoglycans, and polysaccharides – give structura; support and organisation Some proteins interact with cell surface receptors
61
What happens to the ECM in cancer
Upregulation of various collagen types, fibroectin, proteoglycans
62
Types of ECM rich environments within tissues
Basement membrane (basal lamina) - provides separation between different tissues: - more compact and less porous - underlying epithelial & endothelial cells, acts as barrier - type IV collagen, laminin, fibronectin Interstitial matrix (between cells): - highly negatively charged, hydrated, and provides tensile strength to tissues (able to handle large amounts of stress before it breaks) - fibrillar collagen (type I), proteoglycans, fibronectin, tenascin-C
63
Explain desmoplasia
also called desmoplastic response: Secondary to the formation of the cancer Forms around tumour and consists of cancer-associated fibroblasts (myofibroblasts – have muscle cell characteristics, e.g. alpha-smooth muscle actin), they can remodel the ECM Usually associated with malignant tumours (poor prognosis) Growth of hard, fibrous tissue - rich in collagen and other types of extracellular matrix as well as fibroblast cell types
64
Name of the stain used to show increased collegen in desmoplasia
Masson's trichome stain (blue for collagen)
65
Mechanisms of ECM function in cancer
Barrier to therapy Signallig to cancer cells Biomechanical force ECM fragments can also signal, and act as a co-receptor activating signal Act as cell migration tracks for cancer cells to metastisize
66
67
Mammary gland transformation and influence of ECM stiffening:
Epithelial cells become disrupted and apical basal polarity is lost, normal gland morphology is lost and ECM is remodelled as tumour progression continued, creates lined fibrils
68
Influence of ECM Rigidity (tension)
Increased ECM deposited = increased ECM tension/regidity - this negatively correlates with patients survival
69
Stromal cell remodelling of the ECM:
TACS= tumour associated collegen signatures Normal ECM (TACS-1): Basement membrane, normal fibroblasts, epithelial cells Predisposed (TACS-2): Pre-alligned collagen, Protease and other factors, cancer cells, CAFs Desmoplasmic ECM (TACS-3): stiffness from collagen, reduced elasticity, intravasation of cancer cells
70
What does TACS stand for?
Tumour-associated collagen signature
71
Hypoxia and tumour metastasis
Hypoxia Inducible Factor 1α (Hif1α) transcription factor – regulated by intracellular oxygen levels → as levels of oxygen decrease, Hif1α protein is not degraded (due to not being hydroxylated) by proteasome and accumulates in the cell This leads to overexpression of plasma membrane receptors (e.g. Met receptor) or angiogenic factors (VEGF), also leads to increased sensitivity to growth factors such as HGF (ligand for MetR) leads to: ECM degradation, EMT, chemotaxis - seek O2 rich regions, angiogenesis
72
How much stiffer is breast cancer tissue than normal tissue
10x
73
Features of LOX
copper dependent amine-oxidase upregulated in a variety of tumours in response to hypoxia (regulated by Hif1α) Oxidizes peptidyl-lysine residues, resulting in reactive aldehydes, leading to inter and intra molecular covalent crosslinks cross-links collagen fibers and other ECM molecules (elastin) promotes ECM stiffening and tumour invasion
74
What leads to ECM stiffening
increased integrin signalling and focal adhesion formation, enhanced PI3 kinase activity, increased cell invasion
75
The Warburg effect
First described by Otto Heinrich Warburg in 1924 It was observed that cancer cells produce energy by a high rate of glycolysis (they rely on higher levels of glycolysis) Production of lactic acid by tumour cells due to anaerobic glycolysis rather than oxidative phosphorylation for energy production – cancer cells rely on glycolysis even if oxygen is available High lactate leads to a high proton concentration → therefore an acidic environment
76
Cancer Imaging – based on cancer cell metabolic activity:
Positron emission tomography (PET) with 2-deoxy-2-[fluorine-18]fluoro-D-glucose (18F-FDG) (a glucose analogue that doesn’t get broken down) – measures gamma radiation from radioactive isotope Exploits cancer cells increased glucose uptake and glycolytic activity observes metabolic abnormalities before phenotypic changes Sensitive technique Can be used to monitor patient’s response to chemotherapy based on metabolic activity (responders and non-responders) - before any reduction in tumour size occurs
77
Example of PET scan after cancer treatment
Patient with Hodgkin's lymphoma - treated with Sirolimus (mTOR inhibator) and vorinostat (Histone deacetylase inhibator) for three cycles, PET scans taken befor and after showed large decrease in glycolytic activity indivcationg cancer cell decrease Subbiah et al 2014
78
Hypoxia and an acidic microenvironment
External pH of solid tumours is acidic due to increased metabolism of glucose as well as poor fluid and gas exchange (perfusion) Activates stress pathways (Reactive oxygen species), inflammatory response – inducing chromosomal instability stimulates the secretion of lysosomal proteases (cysteine cathepsins) and active collagenases (matrix metalloproteinases)
79
80
Fibrobalsts in cancer
Mesenchymal stromal cells, exhibit cell plasticity – different phenotypes depending on tissue of origin/function Normal fibroblasts – reside within connective tissue (interstitial matrix) and synthesise and remodel the extracellular matrix; quiescent (non-dividing) under normal circumstances, just provide a supporting role Cancer associated fibroblasts Originate from activation of normal fibroblasts by tumour derived growth factors or may result from endothelial to mesenchymal transition (EndMT) TGFβ1, PDGF, bFGF Triggers conversion of fibroblasts, immune cells, pericytes, smooth muscle cells, adipocytes (many normal cell types can turn into CAFs) Increased proliferation rate, enhanced ECM production and ECM remodeling – enhance tumourigenesis
81
CAF features
CAFs facilitate transformation – may infiltrate the tumour or reside at the tumour margins CAFs: Express high levels of alpha-smooth muscle actin, fibroblast specific protein 1, extracellular matrix (e.g. periostin, tenascin-C), fibroblast activation protein (FAP) FAP – type II integral membrane serine protease; restricted to reactive fibroblasts; detected on the surface of fibroblasts in stroma surrounding >90% of epithelial cancers; may have role in matrix digestion, immunosuppression e.g. of NK cells secrete growth factors – promote paracrine signaling Example: Stroma derived factor 1 (SDF-1α)/CXCL12 interacts with CXCR4 (receptor) on tumour cells and promotes cell migration
82
SDF-1/CXCR4 signaling:
Fibroblasts react to local environment e.g. higher levels of TGFb1, causing change of a cell into a CAF, this then drives growth factors e.g. SDF-1, this causes autocrine signalling loop driving differentiation/activation of fibroblasts, and a paracrine signaling pathway (SDF-1 binds to CXCR4 receptor) causing increase cell proliferation and motility of cancer cell itself (by increasing signaling pathways e.g. ERK1/2, PI3K/Akt) SEE DIAGRAM
83
Other functions of CAFs
Tumour angiogenesis: releasing growth factors (VEGF, FGF) recruiting endothelial precursor cells Extracellular Matrix (ECM): -Remodeling ECM architecture, exposing cryptic binding sites (allowing for alternative interactions to occur) --promotes cancer cell migration -ECM stiffening --modulate intercellular adhesion and cell contractility – disrupts tissue organisation, promotes cell migration Tumour-related inflammation: -Recruiting immune cells (monocytes, macrophages) -Modulate function of immune cells --Pro-inflammatory signalling --Inhibiting Natural Killer cell and CD8+ cytotoxic T-lymphocyte function
84
Tumour stroma and its influence on cancer therapy
Ligands derived from activated fibroblasts may signal to receptor (e.g. receptor tyrosine kinases) on tumour cells (paracrine signalling) – leading to therapeutic resistance (e.g. pro-survival signalling) Fibroblasts and extracellular matrix may provide a physical barrier or an avenue for metastasis Impaired drug delivery – - Density of the tumour stroma - Lack of vasculature - inefficient blood flow
85
Name an autofluorescent chemotherapeutic drug for treatment of pancreatic ductal carcinoma
Doxorubicin RW
86
Immune system in the TME
Infiltration of immune cells, such as macrophages, contributes to cancer progression – promoting survival and immunosuppressive environment Release of pro-inflammatory cytokines, such as TNFα, may also promote survival and resistance to chemotherapy
87